Date:8/18/2011

s, a large-scale analysis, which combined the findings of original research and existing, related research in the field of the study, was performed. The study compiled and analyzed data for the 50 largest U.S. metropolitan areas. To determine these Hypertension Hot Spots, Sperling's BestPlaces analyzed data about the following factors: self-reported diagnoses of hypertension, self-reported diagnoses of high cholesterol, self-reported diagnoses of cardiovascular disease, doctor diagnoses of hypertension (per capita), prescriptions of hypertension-control medication (per capita), mortality relating to hypertension, average Body Mass Index (BMI), obesity rate, smoking incidence and lack of exercise. The data came from the following sources: The Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System, The CDC Wide-ranging Online Data for Epidemiologic Research (WONDER) database, The Gallup/Healthways Well-Being poll and ESRI data derived from the Doublebase Consumer Survey performed by Mediamark Research Inc. The analysis weighed the study's categories by assigning each a magnitude of importance based upon the focus of the study; some categories offered more insight into the prevalence of hypertension. All data was adjusted by the current population to arrive at "per capita" figures to provide an accurate comparison between cities of varying sizes.

About Bert Sperling

For more than twenty years, Bert Sperling has been helping people find their own Best Places to live, work, play and retire. As the foremost creator of these studies, his work appears in the national media nearly every month. Annually, his "Healthiest Cities for Women" study is featured in SELF magazine. Other health-related projects include "Migraine Hot Spots," "Asthma Hot Spots," "Best Cities for Sleep," "America's Healthiest Cities," "Best and Worst Cities for Skin Care" and "Most Visually Inspiring Places in America." Sperling's informati
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
2. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
3. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
4. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
5. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
6. Chemosensitivity/Resistance Assay Included as Part of the NCCN Principles of Chemotherapy
7. Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance
8. Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase
9. Additional 8 Products of DK Sinopharma, Inc. are Included in 2010 Provincial Medical Insurance Catalogs in 4 Separate Provinces in the Peoples Republic of China
10. OVA1 Included in Latest ACOG/SGO Committee Opinion
11. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions